Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcadia Biosciences (RKDA) Return on Capital Employed (2016 - 2025)

Arcadia Biosciences' Return on Capital Employed history spans 11 years, with the latest figure at 0.45% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 15.0% year-over-year to 0.45%; the TTM value through Dec 2025 reached 0.45%, down 15.0%, while the annual FY2025 figure was 0.31%, 5.0% down from the prior year.
  • Return on Capital Employed reached 0.45% in Q4 2025 per RKDA's latest filing, up from 0.58% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.07% in Q3 2021 to a low of 0.72% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 0.39%, with a median of 0.45% recorded in 2025.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 110bps in 2021, then plummeted -79bps in 2022.
  • A 5-year view of Return on Capital Employed shows it stood at 0.42% in 2021, then crashed by -48bps to 0.62% in 2022, then increased by 29bps to 0.44% in 2023, then grew by 30bps to 0.31% in 2024, then crashed by -47bps to 0.45% in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Return on Capital Employed are 0.45% (Q4 2025), 0.58% (Q3 2025), and 0.47% (Q2 2025).